GlassScriptPhysician profile
Marcelino Dsouza
NPI 1790899458
$2,943.14
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $356 · 2021: $891 · 2022: $922 · 2023: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $430.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $519.21 | 2019-2023 | Lo Loestrin Fe |
| Amgen INC. | $372.86 | 2019-2021 | |
| Myovant Sciences INC. | $351.46 | 2021-2022 | |
| Agile Therapeutics, INC. | $211.73 | 2021-2022 | |
| Therapeuticsmd, INC. | $194.41 | 2020-2022 | |
| Novo Nordisk INC | $170.27 | 2020-2021 | |
| Gilead Sciences, INC. | $144.73 | 2023 | Epclusa |
| Mayne Pharma Commercial LLC | $118.48 | 2021-2023 | |
| Daiichi Sankyo INC. | $117.50 | 2021-2022 | |
| Sage Therapeutics, LLC | $111.37 | 2020 | |
| Mylan Pharmaceuticals INC. | $109.82 | 2021-2022 | |
| Pfizer INC. | $103.38 | 2020-2023 | |
| Astellas Pharma US INC | $69.13 | 2022-2023 | Veozah, Myrbetriq |
| Exact Sciences Corporation | $60.34 | 2023 | Cologuard Collection Kit |
| Shield Therapeutics INC | $39.22 | 2023 | Accrufer |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $36.48 | 2020-2023 | |
| Merck Sharp & Dohme LLC | $35.58 | 2021-2022 | |
| Roche Diagnostics Corporation | $30.24 | 2021 | |
| Mycovia Pharmaceuticals, INC. | $28.13 | 2023 | Vivjoa |
| Exeltis, USA INC. | $27.46 | 2022-2023 | Slynd |
| Abbott Laboratories | $22.51 | 2022 | |
| Hologic Sales and Service, LLC | $21.54 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.92 | 2022 | |
| Janssen Pharmaceuticals, INC | $16.56 | 2019 | |
| Edwards Lifesciences Corporation | $13.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcelino Dsouza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.